Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Oxalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 8/20 | 0.60 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.49 |
| ▸ | CCR8 | P51685 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxalic Acid SCHEMBL6486537 | 1.00 | SLC2A1 (0.60) | SLC2A1KCNH2CCR8 | |
| Oxalic Acid SCHEMBL6484327 | 1.00 | SLC2A1 (0.60) | SLC2A1KCNH2CCR8 | |
| Oxalic Acid SCHEMBL6486545 | 1.00 | SLC2A1 (0.60) | SLC2A1KCNH2CCR8 | |
| Oxalic Acid SCHEMBL6484323 | 1.00 | SLC2A1 (0.60) | SLC2A1KCNH2CCR8 | |
| Oxalic Acid SCHEMBL6484824 | 1.00 | SLC2A1 (0.60) | SLC2A1KCNH2CCR8 | |
| Oxalic Acid SCHEMBL6484821 | 1.00 | SLC2A1 (0.60) | SLC2A1KCNH2CCR8 | |
| SCHEMBL6498402 | 0.95 | SLC2A1 (0.60) | SLC2A1KCNH2CCR8 | |
| SCHEMBL6645394 | 0.95 | SLC2A1 (0.60) | SLC2A1KCNH2CCR8 | |
| SCHEMBL6645390 | 0.95 | SLC2A1 (0.60) | SLC2A1KCNH2CCR8 | |
| SCHEMBL6645387 | 0.95 | SLC2A1 (0.60) | SLC2A1KCNH2CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6911442-B1 | Quinoline derivatives as antibacterials | SMITHKLINE BEECHAM P.L.C. (GB) | 2005-06-28 | — | — | US | claimed |
| EP-1187828-B1 | QUINOLINE DERIVATIVES AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 2004-04-21 | — | — | EP | claimed |
| US-6911442-B1 | Quinoline derivatives as antibacterials | SMITHKLINE BEECHAM P.L.C. (GB) | 2005-06-28 | — | — | US | disclosed |
| EP-1187828-B1 | QUINOLINE DERIVATIVES AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 2004-04-21 | — | — | EP | disclosed |
| EP-1187828-A1 | QUINOLINE DERIVATIVES AS ANTIBACTERIALS | SMITHKLINE BEECHAM PLC (GB) | 2002-03-20 | — | — | EP | disclosed |
| WO-2000078748-A1 | QUINOLINE DERIVATIVES AS ANTIBACTERIALS | SMITHKLINE BEECHAM P.L.C. (GB) | 2000-12-28 | — | — | WO | disclosed |